Centrient Pharmaceuticals to boost statins manufacturing capacity
Doubling our API capacity to meet the growing demand for high-quality Atorvastatin and Rosuvastatin
With a dedicated statins production facility in India, Centrient Pharmaceuticals is one of the largest commercial statin producers worldwide today.
As a result of the continued growth of the global Atorvastatin and Rosuvastatin market and an increased interest in Centrient Pharmaceuticals’ uniquely produced statins, we are proud to announce that we have decided to further expand our API statins facility.
With the groundbreaking on November 28th, we celebrated the official start of the factory expansion.
With a doubling of the production capacity forthcoming, we are committed to maintain our leadership position and to continue to support our customers now and in the future.
